Christina Cantin, Wenbin Li, Erna Snelgrove-Clarke, Daniel Corsi, Cindy-Lee Dennis, Amanda Ross-White, Susan Brogly, Laura Gaudet
{"title":"Neonates With In-Utero SSRI Exposure (NeoWISE): a retrospective cohort study examining the effect of newborn feeding method on newborn withdrawal.","authors":"Christina Cantin, Wenbin Li, Erna Snelgrove-Clarke, Daniel Corsi, Cindy-Lee Dennis, Amanda Ross-White, Susan Brogly, Laura Gaudet","doi":"10.23889/ijpds.v9i2.2458","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Up to 30% of newborns with in-utero selective serotonin reuptake inhibitor (SSRI) exposure experience withdrawal symptoms. The impact of newborn feeding method on alleviating withdrawal has not been investigated. We examined the effect of newborn feeding method (breastfeeding versus formula) among a cohort of <b>Neo</b>nates <b>W</b>ith <b>I</b>n-utero <b>S</b>SRI <b>E</b>xposure (NeoWISE).</p><p><strong>Methods: </strong>This population-based retrospective cohort study included newborns born in Ontario hospitals between April 1, 2012, and March 31, 2020 to Ontario Drug Benefit Program beneficiaries who filled at least one SSRI prenatal prescription. Linked administrative health and registry data were used. Method of newborn feeding was available from birth to hospital discharge. The primary outcome was newborn withdrawal. The secondary outcome was transfer to the Neonatal Intensive Care Unit (NICU). Adjusted risk ratios (adjRR) in breast- versus formula-fed newborns and our outcomes were estimated using generalized linear models. Propensity scores based on antepartum and intrapartum characteristics and inverse probability of treatment weighting were used to balance differences in maternal-newborn characteristics by treatment.</p><p><strong>Results: </strong>Overall, 5,079 newborns were included in the NeoWISE Cohort, with 3,321 (65.4%) exclusively breastfeeding from birth to hospital discharge. Among the breastfed newborns, 50 (1.5%) had neonatal withdrawal versus 41 (2.3%) in the formula-fed newborns. There was no difference in risk of withdrawal in breast versus formula-fed newborns (adjRR 0.86, 95% CI 0.56, 1.34). Breastfed newborns had a reduced risk of transfer to the NICU compared to formula-fed newborns (adjRR 0.80, 95% CI 0.66, 0.97); however, this finding did not persist in sensitivity analysis.</p><p><strong>Conclusion: </strong>The rate of newborn withdrawal was low in this cohort of SSRI-exposed neonates and was not associated with feeding method in the hospital. The results of this study inform shared decision-making around newborn feeding for perinatal women who take SSRI medications.</p>","PeriodicalId":36483,"journal":{"name":"International Journal of Population Data Science","volume":"9 2","pages":"2458"},"PeriodicalIF":1.6000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638808/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Population Data Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23889/ijpds.v9i2.2458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Up to 30% of newborns with in-utero selective serotonin reuptake inhibitor (SSRI) exposure experience withdrawal symptoms. The impact of newborn feeding method on alleviating withdrawal has not been investigated. We examined the effect of newborn feeding method (breastfeeding versus formula) among a cohort of Neonates With In-utero SSRI Exposure (NeoWISE).
Methods: This population-based retrospective cohort study included newborns born in Ontario hospitals between April 1, 2012, and March 31, 2020 to Ontario Drug Benefit Program beneficiaries who filled at least one SSRI prenatal prescription. Linked administrative health and registry data were used. Method of newborn feeding was available from birth to hospital discharge. The primary outcome was newborn withdrawal. The secondary outcome was transfer to the Neonatal Intensive Care Unit (NICU). Adjusted risk ratios (adjRR) in breast- versus formula-fed newborns and our outcomes were estimated using generalized linear models. Propensity scores based on antepartum and intrapartum characteristics and inverse probability of treatment weighting were used to balance differences in maternal-newborn characteristics by treatment.
Results: Overall, 5,079 newborns were included in the NeoWISE Cohort, with 3,321 (65.4%) exclusively breastfeeding from birth to hospital discharge. Among the breastfed newborns, 50 (1.5%) had neonatal withdrawal versus 41 (2.3%) in the formula-fed newborns. There was no difference in risk of withdrawal in breast versus formula-fed newborns (adjRR 0.86, 95% CI 0.56, 1.34). Breastfed newborns had a reduced risk of transfer to the NICU compared to formula-fed newborns (adjRR 0.80, 95% CI 0.66, 0.97); however, this finding did not persist in sensitivity analysis.
Conclusion: The rate of newborn withdrawal was low in this cohort of SSRI-exposed neonates and was not associated with feeding method in the hospital. The results of this study inform shared decision-making around newborn feeding for perinatal women who take SSRI medications.
高达30%的新生儿与子宫内选择性血清素再摄取抑制剂(SSRI)暴露经历戒断症状。新生儿喂养方法对缓解戒断反应的影响尚未调查。我们研究了新生儿喂养方式(母乳喂养vs配方奶)对子宫内SSRI暴露(NeoWISE)新生儿队列的影响。方法:这项以人群为基础的回顾性队列研究纳入了2012年4月1日至2020年3月31日期间在安大略省医院出生的新生儿到安大略省药物福利计划受益人,这些受益人至少服用了一种SSRI产前处方。使用了关联的管理运行状况和注册中心数据。新生儿喂养方法从出生到出院。主要结局为新生儿戒断。次要结局是转到新生儿重症监护病房(NICU)。母乳喂养与配方奶喂养新生儿的调整风险比(adjRR)和我们的结果使用广义线性模型进行估计。使用基于产前和产时特征的倾向得分和治疗加权逆概率来平衡治疗对母婴特征的差异。结果:总的来说,5079名新生儿被纳入NeoWISE队列,其中3321名(65.4%)从出生到出院全母乳喂养。在母乳喂养的新生儿中,50例(1.5%)出现新生儿戒断反应,而配方奶喂养的新生儿中有41例(2.3%)出现戒断反应。母乳喂养的新生儿与配方奶喂养的新生儿在停药风险上没有差异(相对危险度0.86,95% CI 0.56, 1.34)。与配方奶喂养的新生儿相比,母乳喂养的新生儿转到新生儿重症监护病房的风险降低(adjRR 0.80, 95% CI 0.66, 0.97);然而,这一发现并没有在敏感性分析中持续存在。结论:ssri暴露的新生儿戒断率较低,与医院喂养方式无关。本研究的结果为服用SSRI药物的围产期妇女在新生儿喂养方面的共同决策提供了信息。